Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971 Purpose: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results